BUFORD, Ga.--(BUSINESS WIRE)--Theragenics Corporation (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has entered into a new unsecured credit agreement with Wachovia Bank, National Association. Wachovia is a Wells Fargo company. The new credit agreement consists of a $30 million revolving credit facility and a $10 million term loan. Maximum borrowings under the revolving credit facility can be increased to $40 million under an accordion feature. This new credit agreement replaces and refinances the $40 million revolving credit facility with Wachovia that was set to expire in October 2009. Borrowings of $32 million were outstanding under the old credit facility. The financial covenants in the new credit agreement are substantially similar to the previous credit agreement, except that the requirement to maintain at least $20 million in liquid assets has been reduced to $10 million.
